Education
About Us
Working with TipRanks
Follow Us
Yubo International Biotech (YBGJ)
OTHER OTC:YBGJ
Total Valuation
Yubo International Biotech has a market cap or net worth of $2.04M. The enterprise value is $1.37M.
Market Cap$2.04M
Enterprise Value$1.37M
Share Statistics
Yubo International Biotech has 170,416,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding170,416,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Yubo International Biotech’s return on equity (ROE) is 0.52 and return on invested capital (ROIC) is 56.24%.
Return on Equity (ROE)0.52
Return on Assets (ROA)-1.16
Return on Invested Capital (ROIC)56.24%
Return on Capital Employed (ROCE)0.56
Revenue Per Employee192.78
Profits Per Employee-98.63K
Employee Count18
Asset Turnover<0.01
Inventory Turnover5.76
Valuation Ratios
The current PE Ratio of Yubo International Biotech is ―. Yubo International Biotech’s PEG ratio is 0.00.
PE Ratio―
PS Ratio1196.55
PB Ratio-1.21
Price to Fair Value-1.21
Price to FCF-3.10
Price to Operating Cash Flow-0.93
PEG Ratio0.00
Income Statement
In the last 12 months, Yubo International Biotech had revenue of 3.47K and earned -1.78M in profits. Earnings per share was -0.01.
Revenue3.47K
Gross Profit-209.28K
Operating Income-1.77M
Pretax Income-1.98M
Net Income-1.78M
EBITDA-1.80M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.65M and capital expenditures -4.00, giving a free cash flow of -1.65M billion.
Operating Cash Flow-1.65M
Free Cash Flow-1.65M
Free Cash Flow per Share>-0.01
Dividends & Yields
Yubo International Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change-85.29%
50-Day Moving Average0.01
200-Day Moving Average0.03
Relative Strength Index (RSI)37.17
Average Volume (3m)1.51K
Important Dates
Yubo International Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Yubo International Biotech as a current ratio of 0.14, with Debt / Equity ratio of -8.34%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap0.09
Net Debt to EBITDA-0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Yubo International Biotech has paid -206.49K in taxes.
Income Tax-206.49K
Effective Tax Rate0.10
Enterprise Valuation
Yubo International Biotech EV to EBITDA ratio is -2.57, with an EV/FCF ratio of -3.46.
EV to Sales1.33K
EV to EBITDA-2.57
EV to Free Cash Flow-3.46
EV to Operating Cash Flow-3.46
Balance Sheet
Yubo International Biotech has $10.93K in cash and marketable securities with $138.60K in debt, giving a net cash position of -$127.68K billion.
Cash & Marketable Securities$10.93K
Total Debt$138.60K
Net Cash-$127.68K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 740927.78%, with operating margin of -51006.31%, and net profit margin of -51161.47%.
Gross Margin740927.78%
Operating Margin-51006.31%
Pretax Margin-57112.16%
Net Profit Margin-51161.47%
EBITDA Margin-51831.24%
EBIT Margin-57113.60%
Analyst Forecast
The average price target for Yubo International Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―